Recoly N.V. Report issue

For profit Phase 2
Founded: Brussels Belgium (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2005
NCT00245297
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

antihemophilic factor viii human (Hemofil M) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hemophilia A (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1